The world’s leading heart organisations have updated their guidance on high blood pressure, urging earlier and more intensive treatment. The 2025 guideline from the American Heart Association and the American College of Cardiology, published on 14 August 2025, keeps the target below 130 over 80 for all adults with hypertension, and encourages doctors to aim lower still, towards a systolic pressure below 120, in people at higher risk. High blood pressure is the most common and most modifiable risk factor for heart disease, stroke, heart failure and dementia, yet it usually causes no symptoms, so many people do not know they have it. The guideline says treatment should start at 140 over 90, or at 130 over 80 for people with diabetes, kidney disease or a high risk of heart disease. The update also stresses that blood pressure must be measured properly, with the right cuff size, after rest, and confirmed with home or 24-hour readings, because a single high reading in a clinic can mislead. Lifestyle measures remain the foundation: less salt, more fruit and vegetables, regular exercise, a healthy weight and less alcohol, which together can lower pressure as much as a single drug.
What the Evidence Shows
The debate is about how low to go, and for whom. Trials such as SPRINT showed that aiming for a systolic pressure below 120 cut heart attacks, strokes and deaths, but it also caused more dizziness, falls and kidney problems, so the approach has to be tailored to the individual. Older people, people with frailty and those taking many medicines need a more cautious approach. The guideline also recommends starting two medicines in a single pill for many patients, because combination pills work better and are easier to take every day than several separate tablets. For patients, the practical message is to know your numbers: ask for your reading at every appointment, check it at home if you can, and take the medicine every day, because blood pressure treatment only works when it is taken. Reporting and analysis from sources such as The Lancet track the same developments, and specialists following blood pressure target say the direction is now consistent across independent lines of evidence.
The Wider Context
Equity runs through every discussion of blood pressure target. Interventions that require apps, fees or free weekday afternoons reliably reach the people who need them least, so the programmes earning praise are those designed around clinics, workplaces and community venues that already serve everyone. Evaluation reports now publish uptake by income and region as a matter of routine.
What Happens Next
The practical takeaway on blood pressure target is deliberately unglamorous: it works best as part of ordinary, well-delivered care rather than as a standalone fix. Health services are planning on that basis, building the referral routes and follow-up that turn a promising result into population benefit. The gains arrive slowly and then, in the statistics, unmistakably. You can follow related developments in our coverage of health.
It is also worth remembering how quickly the picture in this area has changed before. Positions that looked settled a few years ago have been revised as new data arrived, and the same humility is appropriate now. The strongest coverage of this subject, and the most useful advice, tends to come from sources that update their views openly when the facts move, rather than defending an earlier position long after it has stopped fitting the evidence available.

